Cargando…
The effect of glucosamine sulphate on osteoarthritis: design of a long-term randomised clinical trial [ISRCTN54513166]
BACKGROUND: Pharmacological treatment for osteoarthritis (OA) can be divided into two groups: symptom-modifying drugs and disease-modifying drugs. Symptom-modifying drugs are currently the prescription of choice for patients with OA, as disease-modifying drugs are not yet available in usual care. Ho...
Autores principales: | Rozendaal, Rianne M, Koes, Bart W, Weinans, Harrie, Uitterlinden, Elian J, van Osch, Gerjo JVM, Ginai, Abida Z, Verhaar, Jan AN, Bierma-Zeinstra, Sita MA |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1090586/ https://www.ncbi.nlm.nih.gov/pubmed/15850497 http://dx.doi.org/10.1186/1471-2474-6-20 |
Ejemplares similares
-
Glucosamine increases hyaluronic acid production in human osteoarthritic synovium explants
por: Uitterlinden, EJ, et al.
Publicado: (2008) -
The PEX study – Exercise therapy for patellofemoral pain syndrome: design of a randomized clinical trial in general practice and sports medicine [ISRCTN83938749]
por: van Linschoten, Robbart, et al.
Publicado: (2006) -
Dual energy x-ray absorptiometry analysis contributes to the prediction of hip osteoarthritis progression
por: Betancourt, Martha C Castaño, et al.
Publicado: (2009) -
Oestrogen is important for maintenance of cartilage and subchondral bone in a murine model of knee osteoarthritis
por: Sniekers, Yvonne H, et al.
Publicado: (2010) -
Incidence and prevalence of upper-extremity musculoskeletal disorders. A systematic appraisal of the literature
por: Huisstede, Bionka MA, et al.
Publicado: (2006)